Arqule Inc Asset Turnover Ratio (ARQL), as of third quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arqule Inc  (ARQL)
 

Arqule Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Arqule Inc's asset turnover ratio, the ratio that measures the ability of Arqule Inc's assets to generate revenue, sequentially decreased to 0.03 in the third quarter (Sep 30 2019), which does not come as a surprise, as the Arqule Inc continue to experience difficult business climate.

Within sector 215 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2019 compared to the preceding quarter from 3628 to 3689.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARQL Asset Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Asset Change 60.23 % 273.04 % 118.33 % 118.14 % 298.54 %
Y / Y Revenue Change -95.82 % -97.95 % -67.5 % - -
Asset Turnover Ratio (TTM) 0.03 0.08 0.25 0.33 0.36
ARQL's Total Ranking # 3689 # 3628 # 879 # 3659 # 0
Seq. Asset Change -3.66 % 90.1 % -7.69 % -5.22 % 124.29 %
Seq. Revenue Change -25.98 % -79.11 % -54.27 % -40.93 % -63.67 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 216
Healthcare Sector # 538
Overall Market # 3689

Asset Turnover Ratio Statistics
High Average Low
6.62 3.84 1.65
(Dec 31 2018)   (Sep 30 2019)




ARQL Company Profile • Back to ARQL Efficiency Comparisons • Compare ARQL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Assets at quarter ending Sep 30 2019
Lexaria Bioscience Corp   0.07 $ 0.223  Millions$ 3.209  Millions
Aclaris Therapeutics Inc   0.07 $ 15.558  Millions$ 226.601  Millions
Oramed Pharmaceuticals Inc  0.07 $ 2.703  Millions$ 40.326  Millions
Lite Strategy Inc   0.07 $ 5.583  Millions$ 83.454  Millions
Verastem Inc   0.06 $ 15.049  Millions$ 232.936  Millions
Chimerix Inc   0.06 $ 10.586  Millions$ 164.974  Millions
Cue Biopharma Inc   0.06 $ 2.740  Millions$ 44.379  Millions
Assembly Biosciences Inc   0.06 $ 14.931  Millions$ 248.037  Millions
Ibio inc   0.06 $ 2.081  Millions$ 36.127  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.062  Millions$ 18.497  Millions
Nektar Therapeutics  0.06 $ 120.581  Millions$ 2,126.150  Millions
Vaccinex Inc   0.05 $ 0.717  Millions$ 13.313  Millions
Five Prime Therapeutics Inc   0.05 $ 15.695  Millions$ 297.187  Millions
Endonovo Therapeutics Inc   0.05 $ 0.204  Millions$ 3.886  Millions
Dicerna Pharmaceuticals Inc   0.05 $ 18.365  Millions$ 372.669  Millions
Inovio Pharmaceuticals Inc   0.05 $ 7.728  Millions$ 159.721  Millions
Parallax Health Sciences Inc   0.05 $ 0.079  Millions$ 1.635  Millions
Chinook Therapeutics Inc   0.05 $ 16.383  Millions$ 341.098  Millions
Wave Life Sciences Ltd   0.05 $ 17.203  Millions$ 364.828  Millions
Accelerate Diagnostics Inc   0.05 $ 7.649  Millions$ 165.843  Millions
Infinity Pharmaceuticals Inc   0.04 $ 2.888  Millions$ 65.627  Millions
Sorrento Therapeutics Inc   0.04 $ 25.327  Millions$ 595.370  Millions
Fate Therapeutics Inc   0.04 $ 9.539  Millions$ 243.495  Millions
Arbutus Biopharma Corp  0.04 $ 6.071  Millions$ 155.041  Millions
Editas Medicine Inc   0.04 $ 14.366  Millions$ 381.821  Millions
Electrocore Inc   0.04 $ 2.083  Millions$ 57.661  Millions
Rafael Holdings Inc  0.04 $ 5.006  Millions$ 142.541  Millions
Evolutionary Genomics Inc   0.03 $ 0.154  Millions$ 4.418  Millions
Kindred Biosciences Inc   0.03 $ 4.181  Millions$ 120.393  Millions
Plx Pharma Inc   0.03 $ 0.829  Millions$ 24.013  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.